Chemours Co is targeting net Leverage below 3.0x, versus 4.4x in Q2 2026, while pursuing Earnings growth and gross Debt reduction through future cycles. The plan matters because the presentation ties its 2027 pathway to improved cash flow, higher-value AI infrastructure markets and a stronger earnings foundation.

Key Highlights

  • The presentation identifies net leverage below 3.0x, compared with 4.4x in the second quarter of 2026.
  • Trailing-twelve-month free-cash-flow conversion reached approximately 30% through June 30, 2026.
  • Chemours is targeting net leverage below 3.0x through future cycles.

Chemours Co (NYSE: CC) is targeting net leverage below 3.0x, compared with 4.4x in the second quarter of 2026, while pursuing earnings growth and gross debt reduction through future cycles. The company’s plan calls for continued execution through 2027 as it builds a foundation for growth in AI infrastructure-related markets.

Segment Sales and Earnings Profile

The presentation also lists year-end free-cash-flow conversion at 7% and year-end net leverage at 4.7x. Trailing-twelve-month free-cash-flow conversion was approximately 30% through June 30, 2026.

2027 Pathway Targets AI Infrastructure Growth

Chemours plans to pursue concentrated growth in liquid cooling, data centers, semiconductors and other AI infrastructure end markets. Pricing and cost improvements are intended to drive Titanium Technologies to a $400M mid-cycle adjusted EBITDA floor without a significant change in volumes. Advanced Performance Materials is targeting organic growth as Performance Solutions increases its existing 40%+ concentration in emerging AI infrastructure markets. The presentation shows 2025 adjusted EBITDA of $742M and an adjusted EBITDA figure of +$1B. It also says forward-looking statements are not guarantees and remain subject to risks including environmental liabilities, regulatory proceedings, litigation, supply-chain disruptions and changes in demand.